Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLCBCYC · Entity 5993 | Director | January 02, 2026 | January 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BICYCLE THERAPEUTICS PLC
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 32,500 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 9,500 · Balance 32,500 F1: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026. F2: Each RSU represents a contingent right to receive one ordinary share. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.08 · Expires 2036-01-02 | Direct | 19,000 |
Reported balance
After 2026-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-02 · Grant · Acquired 19,000 · Balance 19,000 F3: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.
F2: Each RSU represents a contingent right to receive one ordinary share.
F3: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2026 Filed Jan 6, 2026 20:00 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 19,000 | $0.00 Strike: $7.08 | $0.00 |
DisclosureSEC source: 0001783330-26-000002 · form4-01062026_080105.xml · derivative · entry 2 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Underlying: Ordinary Shares · 19,000 shares Expires 2036-01-02 F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 20:00 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantOrdinary Shares | 9,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001783330-26-000002 · form4-01062026_080105.xml · nonDerivative · entry 1 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,500 F1 · shares: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026. F2 · price: Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 19:30 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000915 · form4-01062025_070101.xml · derivative · entry 2 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Ordinary Shares · 12,500 shares Expires 2035-01-02 F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2025, June 15, 2025, September 15, 2025 and December 15, 2025. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 19:30 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantOrdinary Shares | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000915 · form4-01062025_070101.xml · nonDerivative · entry 1 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,000 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2025, June 15, 2025, September 15, 2025 and December 15, 2025. F2 · price: Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 18:33 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $18.08 | $0.00 |
DisclosureSEC source: 0001209191-24-000886 · doc4.xml · derivative · entry 2 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Ordinary Shares · 12,000 shares Expires 2034-01-02 F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 18:33 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-000886 · doc4.xml · nonDerivative · entry 1 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,750 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024. F2 · price: Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:10 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 11,500 | $0.00 Strike: $29.60 | $0.00 |
DisclosureSEC source: 0001209191-23-002187 · doc4.xml · derivative · entry 2 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 Underlying: Ordinary Shares · 11,500 shares Expires 2033-01-03 F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:10 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantOrdinary Shares | 5,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002187 · doc4.xml · nonDerivative · entry 1 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,750 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023. F2 · price: Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 17:16 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $60.87 | $0.00 |
DisclosureSEC source: 0001209191-22-001802 · doc4.xml · derivative · entry 2 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2032-01-03 F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 17:16 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantOrdinary Shares | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001802 · doc4.xml · nonDerivative · entry 1 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs are fully vested. F2 · price: Each RSU represents a contingent right to receive one ordinary share. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 17:26 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 19,000 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001209191-21-001327 · doc4.xml · derivative · entry 1 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Underlying: Ordinary Shares · 19,000 shares Expires 2031-01-04 Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:53 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 8,202 | $0.00 Strike: $9.82 | $0.00 |
DisclosureSEC source: 0001209191-20-001921 · doc4.xml · derivative · entry 2 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,202 Underlying: Ordinary Shares · 8,202 shares Expires 2030-01-02 F1 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following July 18, 2019. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:53 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $9.82 | $0.00 |
DisclosureSEC source: 0001209191-20-001921 · doc4.xml · derivative · entry 1 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Ordinary Shares · 16,000 shares Expires 2030-01-02 Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 16:36 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | GrantStock Option (Right to Buy) · Derivative | 23,798 | $0.00 Strike: $11.66 | $0.00 |
DisclosureSEC source: 0001209191-19-051098 · doc4.xml · derivative · entry 1 Bourque Janice · CIK 0001783330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,798 Underlying: Ordinary Shares · 23,798 shares Expires 2029-09-26 F1 · derivative.exercise_date: The shares underlying this option shall vest in 36 equal monthly installments commencing on July 18, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.